ALE.F02

· Alentis Therapeutics AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALE.F02, covering 2024-12-03 to 2024-12-03. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial of ALE.F02 in Patients With Advanced Liver Fibrosis and/or With Mild Cirrhosis [Phase 1]